Hepatitis-A-virus exposure in the Gambia

The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.

Journal of viral hepatitis·2008

Surveillance of HIV-1 genetic subtypesand diversity in the US blood supply.

Transfusion·2000

A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness.

The Journal of infectious diseases·1998

Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group.

American journal of epidemiology·1997

Comparative rates of disease progression among persons infected with the same or different HIV-1 strains. The Transfusion Safety Study Group.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1997

Divergence of HIV-1 quasispecies in an epidemiologic cluster.

AIDS (London, England)·1997

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Improving inclusivity in UK clinical trials through good practice in the collection and use of ethnicity data: recommendations from the INCLUDED study.

BMJ evidence-based medicine·2026

Metagenomic analysis of tongue samples from healthy subjects identifies distinct microbiome orotypes.

Journal of oral microbiology·2026

Reimagining accessible refugee resettlement: A call for integrating reliable, rights-based disability data.

Disability and health journal·2026

Arts informed indigenous research: Listening to Indigenous Peoples' knowledges in health professions education.

Medical education·2026

Impact of geographical location on ICU outcomes in adults: a scoping review.

BMJ open·2026

Gut microbiomes of tribal communities in India vary with dairy and grain consumption.

Gut microbes·2026

Related Experiment Videos

Hepatitis-A-virus exposure in the Gambia

Related Concept Videos

The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.

Surveillance of HIV-1 genetic subtypesand diversity in the US blood supply.

A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness.

Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group.

Comparative rates of disease progression among persons infected with the same or different HIV-1 strains. The Transfusion Safety Study Group.

Divergence of HIV-1 quasispecies in an epidemiologic cluster.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Improving inclusivity in UK clinical trials through good practice in the collection and use of ethnicity data: recommendations from the INCLUDED study.

Metagenomic analysis of tongue samples from healthy subjects identifies distinct microbiome orotypes.

Reimagining accessible refugee resettlement: A call for integrating reliable, rights-based disability data.

Arts informed indigenous research: Listening to Indigenous Peoples' knowledges in health professions education.

Impact of geographical location on ICU outcomes in adults: a scoping review.

Gut microbiomes of tribal communities in India vary with dairy and grain consumption.

Related Experiment Videos

Hepatitis-A-virus exposure in the Gambia

Related Concept Videos

Related Articles